Browse
Explore clinical trials and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
86370 trials found · Page 71 of 4319
-
Brain implant lets paralyzed patients 'Speak' through thoughts
Disease control Recruiting nowThe goal of this study is to improve our understanding of speech production, and to translate this into medical devices called intracortical brain-computer interfaces (iBCIs) that will enable people who have lost the ability to speak fluently to communicate via a computer just by…
Phase: NA • Sponsor: Leigh R. Hochberg, MD, PhD. • Aim: Disease control
Last updated Apr 22, 2026 15:58 UTC
-
CAR-T therapy trial aims to boost remission for myeloma patients
Disease control OngoingThe purpose of this study is to compare the efficacy, safety, and tolerability of ide-cel with lenalidomide (LEN) maintenance to that of LEN maintenance alone in adult participants with Newly Diagnosed Multiple Myeloma (NDMM) who have achieved a suboptimal response post autologou…
Phase: PHASE3 • Sponsor: Celgene • Aim: Disease control
Last updated Apr 15, 2026 16:15 UTC
-
Radiation blitz on all tumors: a new hope for advanced cancer?
Disease control Recruiting nowThis is a phase II/III international multicentre randomized trial. Patients will be randomized in a 1:2 ratio between the standard of care (Arm 1) and SABR (Arm 2) to all sites of disease. The study will start as a phase II trial with an opportunity to convert to a phase III tria…
Phase: NA • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Disease control
Last updated Apr 16, 2026 13:01 UTC
-
Scientists test 'Living Drug' against tough cancers
Disease control Recruiting nowTo find the recommended dose of TROP2- CAR-NK given intraperitoneally (directly into the abdominal cavity) to patients with highgrade serous ovarian cancer that has not responded to previous treatment or is resistant to treatment.
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 21, 2026 12:43 UTC
-
CAR-T therapy challenges standard transplant for blood cancer
Disease control OngoingThe purpose of this study is to compare the efficacy of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Ciltacabtagene Autoleucel versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Autologous Stem Cell Transplant (ASCT) in…
Phase: PHASE3 • Sponsor: Stichting European Myeloma Network • Aim: Disease control
Last updated Apr 20, 2026 16:15 UTC
-
Breakthrough trial aims to cure hepatitis b with Immune-Boosting drugs
Disease control Recruiting nowHepatitis B virus (HBV) infection is a major public health threat in China. At present, a functional cure, also known as clinical cure or sustained Hepatitis B surface antigen (HBsAg) loss, is recommended as the ideal endpoint of HBV treatment. However, HBsAg loss can be achieved…
Phase: PHASE2 • Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Apr 17, 2026 16:10 UTC
-
New heart preservation method could save more lives in transplants
Disease control OngoingThe purpose of this study is to evaluate if Non-Ischemic Heart Preservation (NIHP) of extended criteria donor hearts using the XVIVO Heart Preservation System (XHPS) is a safe and effective way to preserve and transport hearts for transplantation.
Phase: NA • Sponsor: XVIVO Perfusion • Aim: Disease control
Last updated Apr 24, 2026 16:19 UTC
-
New combo aims to beat hepatitis b by waking up immune cells
Disease control Recruiting nowHepatitis B virus (HBV) infection is a major public health threat in China. At present, a functional cure, also known as clinical cure or sustained Hepatitis B surface antigen (HBsAg) loss, is recommended as the ideal endpoint of HBV treatment. However, HBsAg loss can be achieved…
Phase: PHASE2 • Sponsor: The Second Affiliated Hospital of Chongqing Medical University • Aim: Disease control
Last updated Apr 25, 2026 12:41 UTC
-
New pill aims to shield High-Risk hearts from attack and stroke
Disease control OngoingThis is a phase 3, randomized, placebo-controlled study of the efficacy and safety of enlicitide decanoate, an oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, in participants with high cardiovascular risk. The primary objective is to evaluate the efficacy of…
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 20, 2026 16:17 UTC
-
Radiation & surgery trial aims to extend lives in advanced colon cancer
Disease control Recruiting nowThis phase III trial compares total ablative therapy and usual systemic therapy to usual systemic therapy alone in treating patients with colorectal cancer that has spread to up to 4 body sites (limited metastatic). The usual approach for patients who are not participating in a s…
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Apr 20, 2026 16:16 UTC
-
Immune cell therapy shows promise in Hard-to-Treat lymphoma trial
Disease control OngoingThis trial will compare tisagenlecleucel to standard of care in adult participants with relapsed or refractory (r/r) follicular lymphoma.
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 24, 2026 16:18 UTC
-
One-Two punch: new procedure aims to free kidney patients from lifelong drugs
Disease control OngoingThis study will examine the safety and effectiveness of a bone marrow transplant after kidney transplant (from either a living or deceased donor). An investigational medication and other treatments will be given prior to and after the transplant to help protect the transplanted k…
Phase: PHASE1, PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Race against time: two powerful treatments battle suicidal depression in major study
Disease control ENROLLING_BY_INVITATIONThis study is a randomized open-label single-blind non-inferiority comparative effectiveness study of ECT vs. KET for the treatment of Acute Suicidal Depression (ASD).
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Apr 21, 2026 12:43 UTC
-
Heart-Saving pill for chemo patients? major trial underway
Prevention Recruiting nowEMPACT (EMPAgliflozin in prevention of chemotherapy-related CardioToxicity) study is a randomized, multi-center, placebo-controlled, double-blind trial to evaluate efficacy of empagliflozin in prevention of left ventricular (LV) dysfunction in patients receiving high cumulative d…
Phase: PHASE3 • Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology • Aim: Prevention
Last updated Apr 08, 2026 12:03 UTC
-
Personalized vaccine trial offers new hope for Tough-to-Treat ovarian cancer
Disease control Recruiting nowThis phase I/II trial tests the safety, side effects, best dose, and effectiveness of multi-epitope folate receptor alpha-loaded dendritic cell vaccine (FRalphaDC) with pembrolizumab in treating patients with ovarian, fallopian tube, or primary peritoneal cancer (collectively kno…
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 17, 2026 16:10 UTC
-
New drug aims to make risky sickle cell transplants safer
Disease control TerminatedThe purpose of this study is to find out whether siplizumab is safe and effective for patients with SCD undergoing an allogeneic transplant and to prevent development of Graft versus Host Disease (GVHD) and graft failure. The main goals of this study are : * To determine if acut…
Phase: PHASE1, PHASE2 • Sponsor: Columbia University • Aim: Disease control
Last updated Apr 20, 2026 16:15 UTC
-
New drug duo battles advanced bladder cancer in major trial
Disease control OngoingThis study will enroll participants with urothelial cancer (UC). UC can include cancer of the bladder, kidney, or the tubes that carry pee through the body (ureter, urethra). This study will try to find out if the drugs disitamab vedotin with pembrolizumab works better than plati…
Phase: PHASE3 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Apr 14, 2026 13:08 UTC
-
New drug trial aims to keep cervical cancer from returning
Disease control Recruiting nowThis is a phase III, randomized, double-blind, placebo-controlled, multi-center, global study to explore the efficacy and safety of volrustomig in women with high-risk LACC (FIGO 2018 stage IIIA to IVA cervical cancer) who have not progressed following platinum-based CCRT.
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Apr 25, 2026 12:29 UTC
-
New weapons against superbugs: trial tests promising antibiotic combos
Disease control CompletedThis study is a multi-center, randomized, single-blind, parallel-group study to assess the efficacy and safety, when nacubactam is coadministered with cefepime or aztreonam, compared with best available therapy (BAT), in the treatment of patients with cUTI, AP, HABP, VABP, and cI…
Phase: PHASE3 • Sponsor: Meiji Seika Pharma Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Kentucky schools join fight against child trafficking
Prevention Recruiting nowFocus: Intervention \& prevention of child commercial sexual exploitation or trafficking (CST) In Kentucky, familial SU/D increases risk of CST. Primary goal: Implement and evaluate effectiveness of multi-level bystander-informed program (CSTOP Now!) aimed at Kentucky public mid…
Phase: NA • Sponsor: Ann Coker • Aim: Prevention
Last updated Apr 25, 2026 12:41 UTC